---
title: Mark A. Lane, PhD
description: Mark A. Lane, PhD, brings over 33 years of expertise in drug development and regulatory strategies, guiding clients through the complexities of bringing products to market.
image: https://hallorancg.com/hubfs/2024%20Halloran%20Site/About/People/michele%20schneller.png
---
# Mark A. Lane, PhD
|  | ## Mark A. Lane, PhD *VP North American Regulatory Development and Sciences*** ** ** |
| --- | --- |
Mark Lane has more than 33 years of experience in scientific and drug development. His expertise includes cross-functional development from preclinical through market approval, with a particular focus on regulatory and clinical sciences. Specific experience includes crafting of integrated cross-functional development strategies and roadmaps ensuring all critical activities are incorporated into an executable development strategy. Technical expertise includes all types of regulatory agency interactions, such as agency meetings and associated documentation, expedited and specialized programs, and other types of agency correspondence and submissions.
Prior to joining Halloran, Mark led the Pharmalex Integrated Product Development solution area and served as VP of Development Consulting, and before that, was Head of the Global Center for Drug Development at PRA Health Sciences. In these and other previous roles, he was responsible for helping clients and drug development teams develop and execute strategies to advance products through development.
Mark earned a BSc, MSc, and PhD in Physiology from Pennsylvania State University.
[Halloran Consulting Group
](https://hallorancg.com/team/author/halloran-consulting-group)
## RELATED ARTICLES
```json
{
"@context" : "https://schema.org",
"@type" : "Organization",
"address" : {
"@type" : "PostalAddress",
"addressCountry" : "",
"addressLocality" : "Cambridge",
"addressRegion" : "MA",
"postalCode" : "02142",
"streetAddress" : "245 Main Street"
},
"knowsLanguage" : "en",
"logo" : {
"@type" : "ImageObject",
"url" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/Orange%20Tree%20Blue%20Text.png"
},
"name" : "Halloran Consulting Group, a PLG Company",
"url" : "https://hallorancg.com/team/mark-a.-lane-phd"
}
```
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"abstract" : "Mark A. Lane, PhD, brings over 33 years of expertise in drug development and regulatory strategies, guiding clients through the complexities of bringing products to market.",
"author" : {
"@type" : "Person",
"name" : "Halloran Consulting Group"
},
"dateModified" : "June 25, 2026 5 PM",
"datePublished" : "May 26, 2026 3 PM",
"headline" : "Mark A. Lane, PhD",
"image" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/2024%20Halloran%20Site/About/People/michele%20schneller.png",
"inLanguage" : "en",
"keywords" : "[]",
"mainEntityOfPage" : {
"@type" : "WebPage"
},
"name" : "Mark A. Lane, PhD",
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://9483922.fs1.hubspotusercontent-na1.net/hubfs/9483922/Orange%20Tree%20Blue%20Text.png"
},
"name" : "Halloran Consulting Group, a PLG Company"
},
"text" : "Mark A. Lane, PhD VP North American Regulatory Development and Sciences Mark Lane has more than 33 years of experience in scientific and drug development. His expertise includes cross-functional development from preclinical through market approval, with a particular focus on regulatory and clinical sciences. Specific experience includes crafting of integrated cross-functional development strategies and roadmaps ensuring all critical activities are incorporated into an executable development strategy. Technical expertise includes all types of regulatory agency interactions, such as agency meetings and associated documentation, expedited and specialized programs, and other types of agency correspondence and submissions. Prior to joining Halloran, Mark led the Pharmalex Integrated Product Development solution area and served as VP of Development Consulting, and before that, was Head of the Global Center for Drug Development at PRA Health Sciences. In these and other previous roles, he was responsible for helping clients and drug development teams develop and execute strategies to advance products through development. Mark earned a BSc, MSc, and PhD in Physiology from Pennsylvania State University.",
"url" : "https://hallorancg.com/team/mark-a.-lane-phd",
"wordCount" : "373"
}
```
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Halloran Consulting Group",
"url" : "https://hallorancg.com/team/author/halloran-consulting-group"
},
"dateModified" : "2026-06-25T17:24:46.722Z",
"datePublished" : "2026-05-26T15:26:48.000Z",
"headline" : "Mark A. Lane, PhD",
"image" : [ "https://hallorancg.com/hubfs/2024%20Halloran%20Site/About/People/michele%20schneller.png" ],
"mainEntityOfPage" : {
"@id" : "https://hallorancg.com/team/mark-a.-lane-phd",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://hallorancg.com/hubfs/Orange%20Tree%20Blue%20Text.png"
},
"name" : "Halloran Consulting Group"
}
}
```